Evidence map›Paper›PMID 25772484›Full record

ArticleMolecular and cellular biochemistry2015

Decrease of serum adenine nucleotide hydrolysis in an irritant contact dermatitis mice model: potential P2X7R involvement.

R F Zanin, G L da Silva, T Erig, N D M Sperotto, C E Leite, R Coutinho-Silva, A M O Batastini, Fernanda Bueno Morrone

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Purinergic Signalling: Therapeutic Developments.Frontiers in pharmacology · 2017
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

R F ZaninPrograma de Pós-Graduação em Biologia Celular e Molecular, Pontificia Universidade Catolica do Rio Grande do Sul - PUCRS, Porto Alegre, RS, Brazil.
G L da Silva
T Erig
N D M Sperotto
C E Leite
R Coutinho-Silva
A M O Batastini
Fernanda Bueno Morrone
Pontifícia Universidade Católica do Rio Grande do Sul · BRUniversidade Federal de Ciências da Saúde de Porto Alegre · BRUniversidade Federal do Rio de Janeiro · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracellular adenosine 5'-triphosphate (ATP) has significant effects on a variety of pathological conditions and it is the main physiological agonist of P2X7 purinergic receptor (P2X7R). It is known that ATP acting via purinergic receptors plays a relevant role on skin inflammation, and P2X7R is required to neutrophil recruitment in a mice model of irritant contact dermatitis (ICD).The present study investigated the effects of chemical irritant croton oil (CrO) upon ATP, ADP, and AMP hydrolysis in mice blood serum, and the potential involvement of P2X7R. The topical application CrO induced a decrease on soluble ATP/ADPase activities (~50 %), and the treatment with the selective P2X7R antagonist, A438079, reversed these effects to control level. Furthermore, we showed that CrO decreased cellular viability (52.6 % ± 3.9) in relation to the control and caused necrosis in keratinocytes (PI positive cells). The necrosis induced by CrO was prevented by the pre-treatment with the selective P2X7R antagonist A438079. The results presented herein suggest that CrO exerts an inhibitory effect on the activity of ATPDase in mouse serum, reinforcing the idea that ICD has a pathogenic mechanism dependent of CD39. Furthermore, it is tempting to suggest that P2X7R may act as a controller of the extracellular levels of ATP.

Indexed as

Adenine NucleotidesAnimalsAntigens, CDApyraseCroton OilDermatitis, ContactDermatitis, IrritantDisease Models, AnimalHumansHydrolysisKeratinocytesMiceNucleotide DeaminasesPurinergic P2X Receptor AntagonistsReceptors, Purinergic P2X7Adenine NucleotidesAntigens, CDApyraseATP deaminaseCD39 antigenCroton OilNucleotide DeaminasesPurinergic P2X Receptor AntagonistsReceptors, Purinergic P2X7

Identifiers

PMID25772484
OpenAlexW2167182943

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.